Life Sciences Archives -

Life sciences marketing has rapidly evolved to mirror that of consumer retail. There are now more ways than

Automating – and optimising – HCP engagement to maximise commercial success

https://pharmaphorum.com/views-and-analysis/automating-and-optimising-hcp-engagement-to-maximise-commercial-success/

R&D/ Views & Analysis/ Views and analysis

How Design of Experiments enriches life sciences’ findings

mike.hammerton@pharmaphorum.com biological systems, Design of Experiments, High Dimensional Experimentation, Life Sciences, methodology 0 Comment

Design of Experiments (DOE) is a methodology misunderstood by many, understood by some, and actively used by even

How Design of Experiments enriches life sciences’ findings

https://pharmaphorum.com/views-and-analysis/how-design-of-experiments-enriches-life-sciences-findings/

artificial intelligence (AI) in life sciences

Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

The importance of AI literacy in life sciences

mike.hammerton@pharmaphorum.com AI, Biotech, Education, law of increasing return, Life Sciences, pharma, strategy, technology 0 Comment

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of

The importance of AI literacy in life sciences

https://pharmaphorum.com/views-and-analysis/the-importance-of-ai-literacy-in-life-sciences/

R&D/ Views & Analysis/ Views and analysis

Connected customer data: a golden opportunity for pharma marketers

mike.hammerton@pharmaphorum.com customer data, customer experience, data access, Life Sciences, new technologies, pharma marketing 0 Comment

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the

Connected customer data: a golden opportunity for pharma marketers

https://pharmaphorum.com/r-d/connected-customer-data-a-golden-opportunity-for-pharma-marketers/

Sales and Marketing/ Views & Analysis/ Views and analysis

Another inside peek into pharma marketing at PM Society learning event

Nicole Raleigh development, leadership, learning, Life Sciences, pharma, PM Society, strategy, The Red Thread 0 Comment

The PM Society’s ‘Is Pharma Marketing built on Straw, Sticks, or Bricks?’ interactive information afternoon, held at The

Another inside peek into pharma marketing at PM Society learning event

https://pharmaphorum.com/views-and-analysis/another-inside-peek-into-pharma-marketing-at-pm-society-learning-event/

Market Access/ Sustainability/ Transversal Categories/ Views & Analysis/ Views and analysis

Life sciences faces a battle with sustainability, but let’s not forget its successes

mike.hammerton@pharmaphorum.com carbon emissions, COP27, global healthcare, Life Sciences, net zero, Sustainability 0 Comment

We know that the global healthcare sector is a contributor to the warming of our planet. It is

Life sciences faces a battle with sustainability, but let’s not forget its successes

https://pharmaphorum.com/views-and-analysis/life-sciences-faces-a-battle-with-sustainability-but-lets-not-forget-its-successes/

essentail oil drop on green leaf. spa background with copy space

Digital/ R&D/ Views and analysis

New €300m Angelini Ventures fund combines venture creation and direct investments to pave the way for healthcare transformation

mike.smith@pharmaphorum.com Angelini Ventures, digital health, Life Sciences 0 Comment

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in

New €300m Angelini Ventures fund combines venture creation and direct investments to pave the way for healthcare transformation

https://pharmaphorum.com/digital/new-e300m-angelini-ventures-fund-combines-venture-creation-and-direct-investments-to-pave-the-way-for-healthcare-transformation/

News/ News/ Sales and Marketing

GSK to move HQ to central London, as Canary Wharf plans filed

Phil Taylor Biotech, Canary Wharf Group, cluster, GSK, investment, Life Sciences, UK 0 Comment

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters

GSK to move HQ to central London, as Canary Wharf plans filed

https://pharmaphorum.com/news/gsk-to-move-hq-to-central-london-as-canary-wharf-plans-filed/

R&D/ Views & Analysis/ Views and analysis

How eligible patient numbers affect price of rare disease drugs in France

mike.hammerton@pharmaphorum.com CRA, Drug pricing, France, Life Sciences, patient numbers, rare disease 0 Comment

Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice

How eligible patient numbers affect price of rare disease drugs in France

https://pharmaphorum.com/views-and-analysis/how-eligible-patient-numbers-affect-price-of-rare-disease-drugs-in-france/

Trending

Life Sciences

Login